Patents for A61P 19 - Drugs for skeletal disorders (81,981)
06/2008
06/25/2008CN100396321C Preparation of Chinese traditional medicine for treating hyperosteogeny
06/25/2008CN100396312C Chinese medicine for treating rheumatic arthritis and preparing method
06/25/2008CN100396308C Xianlinggubao soft capsule for treating osteoporosis and its preparing method
06/25/2008CN100396305C Chinese medicinal preparation for treating hyperosteogeny and lumbar vertebra protrusion
06/25/2008CN100396286C Use of homoharringtonine and harringtonine in inhibiting vascularization
06/24/2008US7390924 Terphenyl derivatives, preparation thereof, compositions containing same
06/24/2008US7390905 Tachykinin receptor antagonists for use treating e.g. emesis, depression, urinary disorder
06/24/2008US7390821 Administering nicotinic acetylcholine receptor antagonist; ocular diseases; monoclonal antibodies
06/24/2008US7390815 Pyrazole compounds useful as protein kinase inhibitors
06/24/2008US7390630 Method of identifying a compound that selectively inhibits cytokine-stimulated T cell induced production of TNF-alpha by monocytes
06/24/2008US7390625 Apoptosis-associated protein and use thereof
06/24/2008US7390519 Probiotic Lactobacillus salivarius strains
06/24/2008US7390484 Self-contained adipose derived stem cell processing unit
06/19/2008WO2008073395A2 Compositions and methods for cardiac tissue protection and regeneration
06/19/2008WO2008072726A1 1-phenyl 1-thio-d-glucitol derivative
06/19/2008WO2008072682A1 Imidazo[1,2-b]pyridazine derivative
06/19/2008WO2008072658A1 2-phenylnicotinic acid derivative
06/19/2008WO2008072034A1 Macrolide compounds endowed with antiinflammatory activity
06/19/2008WO2008071736A1 Benzamide derivatives as ep4 receptor agonists
06/19/2008WO2008071664A1 Nicotinamide derivative used as a p38 kinase inhibitor
06/19/2008WO2008071605A2 Methods of treating inflammatory diseases
06/19/2008WO2008070960A1 Ibandronate sodium propylene glycol solvate and processes for the preparation thereof
06/19/2008WO2008035207A3 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
06/19/2008US20080147077 Protein stabilization formulations
06/19/2008US20080147065 Flowable carrier compositions and methods of use
06/19/2008US20080146662 Methods and compositions for treatment of cancer pain
06/19/2008US20080146632 Fc Receptor Modulating Compounds and Compositions
06/19/2008US20080146617 Methods of treating inflammatory diseases
06/19/2008US20080146612 Novel Biaromatic Compounds, Inhibitors of the P2X7-Receptor
06/19/2008US20080146606 Novel compounds
06/19/2008US20080146602 3-Chloro-2-[(2,4-dioxo-1,3-oxazolidin-3-yl)methyl]-5,6,7,8-tetrahydro-4-(4-methoxyphenyl)[1]benzothieno[2,3-b]pyridine-7-carboxamide, salts and prodrugs, used as antiinflammatory agents and for treatment of autoimmune diseases
06/19/2008US20080146590 P38 map kinase inhibitors and methods for using the same
06/19/2008US20080146576 N-(1-Phthalazin-1-ylpiperidin-4-yl)amides as EP2 receptor modulators
06/19/2008US20080146566 treatment of diseases mediated by cytokines; N-cyclopropyl-4-methyl-3-(1-oxoisoquinolin-2(1H)-yl)benzamide; rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease, multiple sclerosis, AIDS, septic shock, congestive heart failure, ischaemic heart disease, psoriasis
06/19/2008US20080146561 Certain chemical entities, compositions and methods
06/19/2008US20080146560 1-[4-(4-amino-5-oxo-5H-pyrido[2,3-d]pyrimidin-8-yl)phenyl]-3-(5-tert-butylisoxazol-3-yl)urea; treatment of tyrosine kinase-induced diseases and conditions, such as angiogenesis, cancer, tumour formation, growth and propagation, arteriosclerosis, ocular diseases, such as age-induced macular degeneration
06/19/2008US20080146509 delivery agent, parathyroid hormone, and calcitonin. This composition exhibits increased delivery of parathyroid hormone and/or calcitonin and is useful for the treatment of osteoporosis. The composition also permits simultaneous oral delivery of parathyroid hormone and calcitonin
06/19/2008US20080146507 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
06/19/2008US20080146503 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins
06/19/2008US20080145884 Sfrp and peptide motifs that interact with sfrp and methods of their use
06/19/2008US20080145465 Sesquiterpene lactone extract from artemisia leucodes for reducing inflammation and down-regulating pro-inflammatory gene expression
06/19/2008US20080145450 Delivery or removal of metals from biological systems
06/19/2008US20080145410 An iron-containing complex to treat hyperphosphatemia by adsorbing excess phosphates in the blood; capacity of >140 mg adsorbed phosphate by 1 g complex of an insoluble carbohydrate (starch), polynuclear iron oxide/hydroxide and a soluble glucose; stability; packaging; industrial scale
06/19/2008US20080145392 Bone Graft
06/19/2008US20080145372 Bioreductively-Activated Prodrugs
06/19/2008US20080145367 Using interleukin specific immunoglobulin for treatment and prevention of imflammatory bone disorders
06/19/2008DE102006058209A1 New triterpene type compounds comprising a pentacyclic basic unit of nor-oleanane- or nor-ursane-type, are 11-beta-hydroxysteroid dehydrogenase inhibitors, useful e.g. to treat and prevent diabetes, depression and glaucoma
06/19/2008DE102006058207A1 New triterpene type compounds comprising a pentacyclic basic structure of nor-oleanan- or non-ursan -types are 11-beta-hydroxysteroid dehydrogenase inhibitors, useful e.g. to treat and prevent the diabetes, depression and glaucoma
06/19/2008DE102006053475A1 Zubereitungen zur Hemmung der Prostaglandin E2 Synthese Preparations for the inhibition of prostaglandin E2 synthesis
06/19/2008CA2672631A1 Benzamide derivatives as ep4 receptor agonists
06/19/2008CA2672176A1 1-phenyl 1-thio-d-glucitol derivative
06/19/2008CA2669818A1 Macrolide compounds endowed with antiinflammatory activity
06/18/2008EP1932856A2 IL-8 inhibitors
06/18/2008EP1932840A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
06/18/2008EP1932833A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
06/18/2008EP1932832A1 Triarylcarboxylic acid derivative
06/18/2008EP1932544A1 Gene transfer for treating a connective tissue of a mammalian host
06/18/2008EP1932543A2 Combination therapy for osteoporosis consisting of an estrogen agonist/antagonist and a growth hormone secretagogue
06/18/2008EP1932534A1 Method of inhibiting angiogenesis by using ephrin b2
06/18/2008EP1931676A1 Pyrazolopyrimidines as protein kinase inhibitors
06/18/2008EP1931374A2 Pth formulations and methods of use
06/18/2008EP1931353A2 Osteogenic and anti-adiogenic oxysterols
06/18/2008EP1931349A2 Use of sodium channel blockers for the management of musculoskeletal pain
06/18/2008EP1931328A2 Method of treating a subject suffering from degenerative disc disease using a nitric oxide synthase inhibitor
06/18/2008EP1931199A2 Treating renal disease, burns, wounds and spinal cord injury with selective androgen receptor modulators
06/18/2008EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
06/18/2008EP1257648B1 Antagonistic selective binding agents of osteoprotegerin binding protein
06/18/2008EP1228203B1 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
06/18/2008EP1198479B1 Neovascular-targeted immunoconjugates
06/18/2008CN101203607A Anti-CD-20 monoclonal antibody
06/18/2008CN101203243A Remedy for xanthoma
06/18/2008CN101203230A Modulating angiogenesis with NOD factors such as glucosamine oligosaccharides
06/18/2008CN101203223A Pharmaceutical composition comprising amorphous rosiglitazone
06/18/2008CN101203214A Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
06/18/2008CN101200497A Jellyfish derived kindócollagen and preparation technique thereof
06/18/2008CN101200468A Novel compounds and uses thereof
06/18/2008CN101200460A Dihydrobenzopyrans ketone compound and uses thereof
06/18/2008CN101200450A 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
06/18/2008CN101199833A Compound essential oil of releasing arthritis ache
06/18/2008CN101199815A Medicament compound for treating rheumatism, rheumatoid arthritis
06/18/2008CN101199799A Healthy kidney Xifeng tea
06/18/2008CN101199793A Chinese medicine compound oral administration for treating lumbar hyperosteogeny
06/18/2008CN101199791A Compound Chinese medicine of prevention osteoporosis
06/18/2008CN101199783A Heat-transfer dose medicament for treating soft tissue scathing
06/18/2008CN101199779A Medicament compound for treating acute gout arthritis and preparing method thereof
06/18/2008CN101199778A Compound medicament for treating synovitis
06/18/2008CN101199760A Chinese medicine agent and producing technique thereof
06/18/2008CN101199758A Compound bone patch for treating articular disease
06/18/2008CN101199750A Chinese medicine prescription for treating hyperuricemia
06/18/2008CN101199723A Chinese medicine compound for oral administration for treating lumbar hyperosteogeny
06/18/2008CN101199721A Chinese medicine pill for treating hip necrosis
06/18/2008CN101199713A Chinese medicine compound for treating hyperosteogeny and A Slipped Disc
06/18/2008CN101199707A Bone-knitting plaster for treating fracture and preparing method thereof
06/18/2008CN101199693A Chinese medicine for oral administration for treating lumbar hyperosteogeny
06/18/2008CN101199691A Soaking medicament for treating soft tissue contusion ulcer
06/18/2008CN101199679A Muscle, soft tissue contusion cloth bag patch
06/18/2008CN101199677A Chinese medicine agent for treating injuries from falls, rheumatoid arthritis and preparing method thereof
06/18/2008CN101199650A Tincture dose medicament for treating scapulohumeral periarthritis
06/18/2008CN101199620A Oral administration medicated liquor for treating sprain
06/18/2008CN101199613A Chinese medicine compound for treating lumbar hyperosteogeny